Khetarpal, Sumeet A
Zeng, Xuemei
Millar, John S
Vitali, Cecilia
Somasundara, Amritha Varshini Hanasoge
Zanoni, Paolo
Landro, James A
Barucci, Nicole
Zavadoski, William J
Sun, Zhiyuan
de Haard, Hans
Toth, Ildikó V
Peloso, Gina M
Natarajan, Pradeep
Cuchel, Marina
Lund-Katz, Sissel
Phillips, Michael C
Tall, Alan R
Kathiresan, Sekar
DaSilva-Jardine, Paul
Yates, Nathan A
Rader, Daniel J
Article History
Received: 28 November 2016
Accepted: 25 July 2017
First Online: 21 August 2017
Competing interests
: D.J.R. has previously been paid as a consultant for the following companies: Aegerion, Alnylam, Eli Lily, Pfizer, and Novartis. P.D.J., A.R.T., and D.J.R. are cofounders of Staten Biotechnology BV. In addition, J.A.L., N.B., and W.J.Z. are employees of and hold equity in Staten Biotechnology BV. I.T. is an employee of FairJourney Biologics. H.d.H. is an employee of and holds equity in argenX BVBA. The other authors declare no competing financial interests.